ETH269 8 mg (Doxazosin Mesylate 8 mg)
Pill with imprint ETH269 8 mg is Blue, Elliptical / Oval and has been identified as Doxazosin Mesylate 8 mg. It is supplied by Ethex Corporation.
Doxazosin is used in the treatment of benign prostatic hyperplasia; raynaud's syndrome; high blood pressure and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Doxazosin 8 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for ETH269 8 mg
Doxazosin Mesylate
- Imprint
- ETH269 8 mg
- Strength
- 8 mg
- Color
- Blue
- Size
- 12.00 mm
- Shape
- Elliptical / Oval
- Availability
- Prescription only
- Drug Class
- Antiadrenergic agents, peripherally acting
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Ethex Corporation
- National Drug Code (NDC)
- 58177-0269
More about doxazosin
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 42 Reviews
- Drug class: antiadrenergic agents, peripherally acting
Consumer resources
- Patient Information
- Doxazosin (Advanced Reading)
- Doxazosin Extended-Release Tablets
- Doxazosin Tablets
- Other brands
- Cardura, Cardura XL
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.